ContractConvertible Note Agreement • April 28th, 2017 • Co-Diagnostics, Inc. • Surgical & medical instruments & apparatus • Utah
TIDS NOTE AND THE SHARES ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT BEEN REGISTERED WIIB THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT.
AMENDMENT TO 12% REVOLVING LINE OF CREDIT PROMISSOPRY NOTE DUE 2016 OF CO- DIAGNOSTICS, INC.12% Revolving Line of Credit Promissory Note • April 28th, 2017 • Co-Diagnostics, Inc. • Surgical & medical instruments & apparatus
Whereas, THIS AMENDMENT TO THE 12% PROMISSORY NOTE dated May 15, 2016, as amended (the “Note”) is entered into, by and between Co-Diagnostics, Inc., a Utah corporation (the “Company”) and Hamilton Mining Resources, Inc., a Utah corporation (“Holder”);
STOCK PURCHASE AGREEMENTStock Purchase Agreement • April 28th, 2017 • Co-Diagnostics, Inc. • Surgical & medical instruments & apparatus • Nevada
This Stock Purchase Agreement (“Agreement”) is made and entered into this _____ day of September, 2016, by and between Ted Murphy with an address located at 64 Industrial road, Richmond Hill, Ontario L4C 2Y1 (“Seller”) and Co-Diagnostics, Inc., a Utah corporation, with an address located at 4049 S. Highland Drive, Salt Lake City, Utah 84124.
AMENDED EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • April 28th, 2017 • Co-Diagnostics, Inc. • Surgical & medical instruments & apparatus
This Amendment to Exclusive License Agreement is made and entered into effective January 1, 2017 by and between Co-Diagnostics, Inc. (“Licensee”) and Brent Satterfield (“Licensor”) to that certain license agreement (“License Agreement”) dated April 18, 2014 between Licensee and DNA Logix, Inc. , which as been assigned to Licensor.
MUTUAL RESCISSION AGREEMENTMutual Rescission Agreement • April 28th, 2017 • Co-Diagnostics, Inc. • Surgical & medical instruments & apparatus • New York
THIS MUTUAL RESCISSION AGREEMENT (“Agreement”) is entered into on the dates set forth below but effective as of September 22, 2016 (the “Effective Date”), by and between Co-Diagnostics, Inc., a Utah corporation (the “Company”), and Robert Salna and Ted Murphy, individuals with an address located at 64 Industrial Road, Richmond Hill, Ontario L4C 2Y1, Canada, and comprising all members of the Board of Watermark Group, Inc. n/k/a Zika Diagnostics, Inc. (“Murphy”) and Watermark Group, Inc. n/k/a Zika Diagnostics, Inc., a Nevada corporation (“Watermark”);
CO-DIAGNOSTICS, INC. PROSPERITY INVESTMENTS SUBSCRIPTION AGREEMENTSubscription Agreement • April 28th, 2017 • Co-Diagnostics, Inc. • Surgical & medical instruments & apparatus
REVOLVING LINE OF CREDIT PROMISSORY NOTERevolving Line of Credit Promissory Note • April 28th, 2017 • Co-Diagnostics, Inc. • Surgical & medical instruments & apparatus
WHEREAS, the Borrower desires to borrow funds from the Lender from time to time and the parties desire to enter into a note which provides for advances from time to time on an unsecured basis.
SHAREHOLDERS’ AGREEMENTShareholders Agreement • April 28th, 2017 • Co-Diagnostics, Inc. • Surgical & medical instruments & apparatus
Synbiotics Limited, a company incorporated and registered under the Laws of India under the provisions of Companies Act, 1956, having its registered office at Sarabhai Campus, Gorwa Road, Vadodara – 390 023 (hereinafter referred to as “Synbiotics” which expression shall, unless repugnant to the context or meaning thereof, be deemed to include its successors, assigns and permitted nominees), of the One part
AMENDMENT TO 12% REVOLVING LINE OF CREDIT PROMISSOPRY NOTE DUE 2016 OF CO- DIAGNOSTICS, INC.12% Revolving Line of Credit Promissory Note • April 28th, 2017 • Co-Diagnostics, Inc. • Surgical & medical instruments & apparatus
Whereas, THIS AMENDMENT TO THE 12% PROMISSORY NOTE dated March 1, 2016 as amended (the “Note”) is entered into, by and between Co-Diagnostics, Inc., a Utah corporation (the “Company”) and Legends Capital Group, LLC (“Holder”);
AMENDMENT TO 12% REVOLVING LINE OF CREDIT PROMISSORY NOTE DUE 2016 OF CO- DIAGNOSTICS, INC.12% Revolving Line of Credit Promissory Note • April 28th, 2017 • Co-Diagnostics, Inc. • Surgical & medical instruments & apparatus
Whereas, THIS AMENDMENT TO THE 12% PROMISSORY NOTE dated May 30, 2016, as amended (the “Note”) is entered into, by and between Co-Diagnostics, Inc., a Utah corporation (the “Company”) and Machan 1988 Property Trust (“Holder”);
AMENDMENT TO 12% PROMISSOPRY NOTE DUE 2016 OF CO-DIAGNOSTICS, INC.12% Promissory Note • April 28th, 2017 • Co-Diagnostics, Inc. • Surgical & medical instruments & apparatus
Whereas, THIS AMENDMENT TO THE 12% PROMISSORY NOTE dated February 22, 2016, as amended (the “Note”) is entered into, by and between Co-Diagnostics, Inc., a Utah corporation (the “Company”) and Clavo Rico Incorporated, a Utah corporation (“Holder”);
AMENDMENT TO 12% REVOLVING LINE OF CREDIT PROMISSOPRY NOTE DUE 2016 OF CO- DIAGNOSTICS, INC.12% Revolving Line of Credit Promissory Note • April 28th, 2017 • Co-Diagnostics, Inc. • Surgical & medical instruments & apparatus
Whereas, THIS AMENDMENT TO THE 12% PROMISSORY NOTE dated December 30, 2015, as amended (the “Note”) is entered into, by and between Co-Diagnostics, Inc., a Utah corporation (the “Company”) and Pine Valley Investments, LLC, a Utah limited liability company (“Holder”);
AMENDMENT TO 12% REVOLVING LINE OF CREDIT PROIVIISSOPRY NOTE DUE 2016 OF CO- DIAGNOSTICS, INC.12% Revolving Line of Credit Promissory Note • April 28th, 2017 • Co-Diagnostics, Inc. • Surgical & medical instruments & apparatus
Whereas, THIS AMENDMENT TO THE 12% PROMlSSORY NOTE dated August 1, 2015, as amended (the ''Note") is entered into, by and between Co-Diagnostics, Inc., a Utah corporation (the "Company') and Co-Diagnostics, Ltd, a Turks and Caicos Limited Company ("Holder'');
